Revenue of vaccines in Latin America 2016-2028

Revenue of the vaccines market in Latin America from 2016 to 2028

Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Supplementary notes

Data provided by Statista Market Insights are estimates.

This market covers vaccines against infectious diseases. They help to prevent diseases, usually through active immunization. Vaccines against infectious diseases transmitted by viruses (e.g., hepatitis A and B or COVID-19) and bacteria (e.g., typhoid fever or meningococcus) are included.

Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G). 

Company examples: Pfizer, GlaxoSmithKline, Merck & Co, Sanofi, Moderna, AstraZeneca

Citation formats
Use Statista now: unlimited access to all content

Statistics on " Pharmaceutical industry in Latin America "

Other statistics that may interest you Pharmaceutical industry in Latin America

Global overview

6

Foreign trade

6

Key segments

6

Main players

6

Price and consumption

6

Research and development

6
Use Statista now: unlimited access to all content
Learn more about how Statista can support your business.